Physician profile
Pavan K Karnati
NPI 1952560799
$2,279.99
in general payments reported to CMS, 2019-2025
27 companies · $578 in 2025
The $578 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $45.26 · 2021: $29.72 · 2022: $229 · 2023: $356 · 2024: $699 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,633.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $461.79 | 2023-2025 | |
| Abiomed | $323.88 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $252.93 | 2022-2025 | Lifevest |
| Amgen INC. | $219.59 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $159.10 | 2023-2025 | |
| Abbott Laboratories | $111.06 | 2019-2025 | Cardiomems, Dragonfly Opstar, Aveir |
| Irhythm Technologies, INC. | $108.71 | 2022-2023 | Zio Xt Patch |
| Boston Scientific Corporation | $94.16 | 2022-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $87.77 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $56.17 | 2025 | Lokelma, Farxiga |
| Stryker Corporation | $52.27 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $44.18 | 2024 | Sapien 3 Ultra Resilia |
| Heartflow, INC. | $29.12 | 2025 | |
| Penumbra, INC. | $27.73 | 2024 | Indigo System |
| Impulse Dynamics (USA) INC. | $25.45 | 2023 | Optimizer |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $24.90 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $24.32 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.95 | 2024 | Jardiance |
| Vital Connect, INC | $23.17 | 2025 | Vitalpatch Rtm |
| Siemens Medical Solutions USA, INC. | $21.95 | 2024 | Artis Icono Floor |
| E.R. Squibb & Sons, L.L.C. | $19.42 | 2025 | Camzyos |
| Cardiovascular Systems INC. | $18.00 | 2020 | |
| Scpharmaceuticals INC. | $16.04 | 2025 | |
| Teleflex LLC | $15.42 | 2021 | |
| Amarin Pharma, INC. | $15.03 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.83 | 2019 | |
| Zoll Medical Corporation | $10.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pavan Karnati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.